Effects of Cangrelor on MIcRovAscular Disfunction During Elective Percutaneous CORonary Intervention

Abroad (travel likely)RecruitingPHASE4

Conditions

Coronary Artery Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Division of Cardiology, University Hospital of Ferrara, Ferrara, Italy
Contact: Study coordinator (Gianluca Campo, MD, PhD) · cmpglc@unife.it · +390532236450
Division of Cardiology - Federico II University Hospital, Naples, Italy
Contact: Study coordinator (Giovanni Esposito, MD, PhD) · espogiov@unina.it · +390817463075
Contact: Study coordinator (Luigi Di Serafino, MD, PhD) · luigi.diserafino@unina.it · +390817462235

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Potassium-Competitive Acid Blocker Versus pROton-Pump Inhibitor for GastroproTECTion Strategies In Patients at High Gastro-Intestinal Bleeding Risk Receiving Antithrombotic Therapy

Coronary Artery Disease · Percutaneous Coronary Intervention · Acute Coronary Syndrome

Abroad (travel likely)RecruitingPHASE4

Anyang, South Korea · Bucheon-si, South Korea

Tailored Versus Coventional AntiPlaTelet Strategy Intended After OPTIMIZEd Drug Eluting Stent

Coronary Artery Disease

Abroad (travel likely)RecruitingPHASE4

Bucheon-si, South Korea · Busan, South Korea

CAPRA-EVO: a Randomized Serial PCCT Trial of Early Evolocumab After ACS

Coronary · Coronary Artery Disease

Abroad (travel likely)RecruitingPHASE4

Chengdu, China

Construction of a Prospective Cohort Database for the Perioperative Period of Cardiac Surgery

Valve Heart Disease · Coronary Artery Disease · Coronary Heart Disease

Abroad (travel likely)Recruiting

Hangzhou, China